Introduction
============

Cough is the most frequent morbidity-related reason to visit a physician in the United States,[@b1-ijgm-3-101] Great Britain,[@b2-ijgm-3-101] Australia,[@b3-ijgm-3-101] and Japan.[@b4-ijgm-3-101] Several guidelines for diagnosis and management of cough have been established in the United States,[@b5-ijgm-3-101] Europe,[@b6-ijgm-3-101] and Japan.[@b7-ijgm-3-101] The guidelines established in Japan categorize cough according to the duration of symptoms. Chronic cough is defined as persistent for more than eight weeks. Subacute cough is defined as persistent for three to eight weeks. Acute cough is defined as persistent for less than three weeks.[@b7-ijgm-3-101]

The likelihood of disease causing cough varies according to the duration of cough. In acute cough, causes of most cases are infectious diseases such as common cold or subsequent post-infectious cough. In subacute and chronic cough, the ratio of noninfectious diseases is increased for causes of the cough in accordance with the duration of cough. Major causes of chronic cough are bronchial asthma, postnasal drip and gastro-esophageal reflex disease (GERD) in the United States.[@b5-ijgm-3-101] On the other hand, Fujimura and colleagues reported that main causes of chronic cough without any abnormal findings in chest X-ray test are atopic cough, sinobronchial syndrome and cough variant asthma (CVA) in Hokuriku area of Japan.[@b8-ijgm-3-101] Similar observations are obtained from other areas of Japan.[@b9-ijgm-3-101],[@b10-ijgm-3-101]

The diagnostic procedures also affect cough etiology. The diagnosis of bronchial asthma is made based on symptoms such as cough, wheezing in the early morning or midnight, dyspnea, and chest oppression.[@b11-ijgm-3-101] A main symptom in patients with CVA is chronic cough.[@b12-ijgm-3-101] General examination including chest X-ray test, complete blood counts with eosinophil number, spirometry, and sputum examination might be required for the differential diagnosis of chronic cough, CVA, or bronchial asthma. However, how physicians use these methods for diagnosis of asthma/CVA has not been studied yet. Furthermore, how physicians treat those patients who are diagnosed as asthma/CVA has not been well studied.

In 2003, the 2nd edition of Guideline for Diagnosis and Treatment of Cough was proposed by the Japanese Cough Research Society.[@b7-ijgm-3-101] In this guideline, differential diagnosis of chronic cough and diagnosis criteria for CVA, atopic cough, sinobronchial syndrome (SBS), postnasal drip, GERD, psychogenic cough and postinfectious cough are defined. However, it seems difficult for many general clinic physicians to diagnose patients with cough for bronchial asthma or CVA according to these criteria because of lack of equipment for cough provocation test, and spirometry.

In this study, we investigated the causes of acute, subacute and chronic cough in a rural region of Japan (San-in area) and the diagnostic procedure and treatment of patients who are diagnosed with CVA or bronchial asthma in this area.

Methods
=======

This questionnaire-based study was conducted between April and June 2007 at 19 medical centers and nine clinics in the San-in area of Japan. During this period, 124 patients who visited a doctor for cough were questioned. Therefore, some but not all the patients visited the clinic for the first time for cough. This study was approved by the ethical committee of Tottori University. Informed consent was obtained from all subjects who participated in this study.

To conduct this study, we devised the questionnaire shown in [Table 1](#t1-ijgm-3-101){ref-type="table"} (originally described in Japanese). The spirometry, chest X-ray test, sputum eosinophilia, and complete blood count including absolute eosinophil number, and C-reactive protein were measured by each physician. Final diagnoses of acute, subacute, or chronic cough were made by each physician (acute cough being defined as persistent cough for less than three weeks, and subacute cough being defined as cough for more than three weeks but less than eight weeks, and chronic cough being defined as cough for more than eight weeks).

Statistical analysis
--------------------

Kruskal--Wallis test analysis was used for comparison of age. Statistical analysis was performed with Graph-Pad Prism 4.0 (Graph Pad Software Inc. San Diego, CA). Differences were considered to be statistically significant at *P \<* 0.05.

Results
=======

Characteristics of the patients
-------------------------------

One hundred twenty-four patients visited the clinics complaining of cough. Twenty-five patients suffered acute cough, 45 had subacute cough, and 54 had chronic cough. The average age of the patients with acute cough was the lowest of the three groups, while the average age of the patients with chronic cough was the highest of the three groups. There was statistical difference between the patients with acute cough and chronic cough. The average age of the patients with subacute cough was the second youngest of the three groups and statistical difference was observed between the patients with subacute cough and chronic cough. The number of female patients was larger than that of male in the three groups ([Table 2](#t2-ijgm-3-101){ref-type="table"}).

[Figure 1](#f1-ijgm-3-101){ref-type="fig"} shows the age distribution of the patients. The number of patients with acute and subacute cough was larger under the age of 40 years. The number of patients with chronic cough was larger in most of the patients aged over 50 years ([Figure 1](#f1-ijgm-3-101){ref-type="fig"}).

[Table 3](#t3-ijgm-3-101){ref-type="table"} shows the diagnosis of cough categorized by duration of cough. In the group of patients with acute cough, the percentage with asthma was 28.0%, while bronchitis caused by respiratory tract infection was 72.0%. In the group of patients with subacute cough, the percentage of asthma was 48.8%, the percentage of CVA is 9.7%, while the percentage of other diseases which are related to microorganism was 7.3%. Other causes were post infectious cough (12.2%), chronic obstructive pulmonary disease (COPD) (4.8%), SBS (2.4%), bronchiolitis associated with rheumatoid arthritis (2.4%), and causes of unknown origin (12.2%). In the group with chronic cough, the percentage of asthma was 44.4%; CVA was 9.3%. Other causes were postinfectious cough (11.1%), COPD (14.8%), SBS (7.4%), bronchiolitis associated with rheumatoid arthritis (3.7%), GERD (4.8%) and causes of unknown origin (9.3%).

In this study, the number of patients with CVA was small. Furthermore, since diagnostic process and treatment of asthma and CVA were similar, we analyzed the diagnosis procedure and treatment for patients with asthma and CVA. [Table 4](#t4-ijgm-3-101){ref-type="table"} shows the clinical tests and symptoms for the diagnosis of asthma and CVA. Among patients diagnosed as asthma/CVA in acute cough, chest X-ray test was performed in 57.1%, white blood cell counts with cell differentiation was measured in 42.8%, Immunoglobulin E (IgE) was measured in 14.3%, sputum eosinophilia was examined in 42.8%, and spirometry was performed in 57.1%. The percentage of patients who had typical symptoms of asthma such as wheezing or chest oppression was 85.7%. Among patients diagnosed as asthma/CVA in subacute cough, chest X-ray test was performed in 95.8%, white blood cell counts with cell differentiation was measured in 58.3%, IgE was measured in 25.0%, sputum eosinophilia was examined in 37.5%, and spirometry was performed in 70.8%. The percentage of patients who had typical symptoms of asthma such as wheezing or chest oppression was 54.2%. Among patients diagnosed as asthma/CVA in chronic cough, chest X-ray test was performed in 100.0%, white blood cell counts with cell differentiation was measured in 91.7%, IgE was measured in 72.4%, sputum eosinophilia was examined in 51.7%, and spirometry was performed in 79.3%. The percentage of the patients who had typical symptoms of asthma such as wheezing or chest oppression was 82.8%.

We next analyzed treatment of asthma/CVA according to the duration of cough. [Figure 2](#f2-ijgm-3-101){ref-type="fig"} shows the percentage of antiasthmatic drugs used with patients diagnosed as having asthma and CVA. Among patients with acute asthma/CVA, the percentage of inhaled corticosteroid (ICS) use was 42.0%. But the percentage of ICS use increased according to the duration of cough (subacute, 70.0%; chronic, 100%). A similar trend was observed in leukotriene receptor antagonist (LTRA) use. The percentage of LTRA use increased according to the duration of cough. Among patients with acute cough, use was 30%, with subacute cough, use was 40%, and with chronic cough, use was 60%, while the percentage of long-acting β~2~ agonist (LABA) use decreased according to the duration of cough. The percentage of LABA use was 58% in acute asthma/CVA, 42% in subacute and 40% in chronic cough. The percentages of sustained-release theophylline use were highest in chronic asthma/CVA, second highest in acute asthma/CVA and lowest in subacute asthma/CVA patients. Therefore, there was no correlation in use of sustained-release theophylline in patients with asthma/CVA and duration of asthma.

Discussion
==========

Cough is the most frequent symptom for patients to visit clinic or hospital worldwide including Japan.[@b1-ijgm-3-101],[@b3-ijgm-3-101],[@b4-ijgm-3-101] Many diseases cause cough, but the distribution of diseases causing cough differs according to the duration of cough. The causes of acute or subacute cough tend to be infectious disease[@b13-ijgm-3-101] while the causes of chronic cough are likely noninfectious diseases.[@b8-ijgm-3-101],[@b14-ijgm-3-101] Like previous studies, this study showed that the percentage of infectious diseases was high for causes of acute cough while the percentage of noninfectious diseases increased as the duration of cough became longer.

Causes of chronic cough differ among areas in Japan. Atopic cough and CVA are the most common causes of chronic cough.[@b8-ijgm-3-101],[@b10-ijgm-3-101] In this study, we found that bronchial asthma is the most common cause of chronic cough as well as of subacute cough. The second most common cause for chronic cough is CVA, the third is COPD, and the fourth is postinfectious cough. These differences between our results and others might come from the study period. In this study, we studied for a period of three months from April 1st to June 30th, 2007 while Fujimura and colleagues[@b8-ijgm-3-101] studied for about seven months and Shirahata and colleagues[@b10-ijgm-3-101] studied for over 12 months. Other reasons for these differences could be clinical background since those two studies might have excluded typical asthma and chronic obstructive pulmonary disease from patients complaining of chronic cough because they surveyed patients with no remarkable findings in chest X-ray test and normal spirometry. There are subtle differences among areas of Japan in etiology of chronic cough. Fujimura and colleagues[@b8-ijgm-3-101] reported that CVA/asthma is the most common cause of chronic cough. Atopic cough is the second and sinobronchial syndrome is the third most common cause. Shirahata and colleagues[@b10-ijgm-3-101] and Fujimori and colleagues[@b9-ijgm-3-101] also reported that CVA is the most common causes of chronic cough. However, Shirahata and colleagues[@b10-ijgm-3-101] have reported that the second most common cause is nonspecific and the third most common cause is sinobronchial syndrome. Fujimori and colleagues reported that the second most common cause of the subacute is postinfectious and third most common is atopic cough. The reasons for these differences are not clear. However, confusion, or lack of consensus in disease entities which cause subacute and chronic cough might be one possible reason. Geographic issues such as distribution of general practitioners, local hospital generalists and respiratory physicians also affect the diagnosis of subacute and chronic cough. Therefore, causes of subacute and chronic cough in rural areas of Japan would be somewhat different from those in other studies.

Furthermore, diagnostic procedures or criteria might relate to the subtle differences in diagnosis of chronic cough. Fujimura and colleagues made differential diagnosis according to criteria recommended by the Japanese Cough Research Society.[@b15-ijgm-3-101] In their study, causes of cough were diagnosed symptoms, blood examinations, chest and sinus X-ray tests, examination of sputum eosinophilia, spirometry, capsaicin-induced cough sensitivity, bronchial responsiveness to methacholine and effectiveness of treatment for each disease. However, the precise diagnosis of CVA or atopic cough according to the Japanese Respiratory Society Guidelines[@b7-ijgm-3-101] for general physicians is very difficult. In our study, spirometry was performed on more than half of the patients with CVA/asthma and the percentage of patients who had spirogram increased as to the duration of cough increased, though the percentage did not reach 100%. On the other hand, blood examination is easy to carry out in general clinics and hospitals. The percentage of the patients who had the blood examination carried out including IgE and eosinophils increased according to the duration of cough. However, the percentage of patients with IgE checked was smaller than those who were measured blood eosinophils. This result may indicate that the physicians measured blood white blood cells with differentiation to diagnose or exclude respiratory infectious disease. However, peripheral blood eosinophil as well as basophil percentage are important and useful for diagnosis of bronchial asthma.[@b16-ijgm-3-101] Furthermore, serum IgE is elevated in atopic and nonatopic asthma.[@b17-ijgm-3-101] The percentage of patients who checked sputum eosinophilia was about 50% of the patients who were diagnosed with asthma. The reason for this low percentage might be related to the patients' symptoms because this study was carried out for patients who had cough as a main symptom.

In this study, chest X-ray test was performed in almost all the patients with asthma among chronic cough and subacute cough groups. The diagnostic procedure to exclude diseases such as lung cancer, tuberculosis and interstitial pneumonia, is important because misdiagnosis and mistreatment of these diseases is critical.[@b18-ijgm-3-101]--[@b20-ijgm-3-101] In this study, general physicians as well as pulmonary specialists must be careful to exclude these diseases. Furthermore, consequences of the exclusion of these diseases by chest X-ray test might lead to diagnosis of asthma/CVA. Induced sputum with hypertonic saline might be considered on patients with dry cough to show airway inflammation for diagnosis of asthma/CVA.

In this study, the treatment for asthma/CVA was analyzed. The percentage of ICS use in the patients with acute asthma/CVA was below 50%, but this percentage increased according to the duration of cough and reached 100% in chronic asthma. Similar results were obtained in use of LTRA. In contrast to the use of ICS, the percentage of LABA use was over 50% but decreased according to the duration of cough. Since inhaled bronchodilator is used for the diagnosis and treatment of CVA,[@b21-ijgm-3-101] our results indicate that LABA might be used for acute asthma/CVA patients for treatment as well as for the diagnosis. On the other hand, the ICS might be used for the definite treatment for persistent symptoms such as subacute and chronic cough. ICS is most effective treatment for asthma and should be used in mild persistent, moderate and severe asthmatic patients[@b22-ijgm-3-101] or step 2 or more.[@b23-ijgm-3-101] Furthermore, Fujimura and colleagues have reported that nearly 30% of CVA patients develop typical asthma and no ICS use is one of the risks in developing typical asthma.[@b24-ijgm-3-101] Therefore, the treatment of chronic asthma/CVA in this rural area is compatible with international guidelines.

A number of limitations must be noted in this study. Firstly, the diagnosis of asthma or CVA has been made by each physician with laboratory findings as well as clinical symptoms. Therefore, diagnosis of asthma/CVA depends on each physician. Secondly, we asked the treatment for asthma/CVA according to each physician's diagnosis. This also includes diagnostic therapy. Since the Japanese guideline for diagnosis and management of cough[@b7-ijgm-3-101] recommends using bronchodilator therapy for CVA for the initial diagnosis, it may influence the prevalence of LABA or sustained-release theophylline use. Finally, other disease such as COPD, GERD, or SBS is also diagnosed by each physician. However, our diagnostic procedures might be more practical in rural areas where sophisticated equipment is not readily available.

In the present study, it was difficult for the general physicians to use spirometry, sputum examination, measurement of capsaicin-induced cough sensitivity, and bronchial responsiveness to methacholine for diagnosis of asthma/CVA. However, most of the physicians were good at excluding the patients who were not asthma by checking X-ray test in almost all the patients who were diagnosed as asthma/CVA. Montnemery and colleagues have reported that general physicians are good at excluding patients who do not have asthma but not good at diagnosing patients who actually have asthma in Sweden.[@b25-ijgm-3-101] The precise diagnosis of asthma/CVA patients who complains of cough might be difficult. But clinical symptoms and laboratory tests such as peripheral blood examination, pulmonary function test, sputum examination and chest X-ray test are useful for asthma/CVA diagnosis. Simple diagnostic guidelines for asthma/CVA might be needed for general physicians.

We thank our subjects for their enthusiastic participation. We also thank The San-in Asthma Research Group members. None of the authors have any conflict of interest with the research reported in this manuscript.

The members of the San-In Asthma Research Group are as follows: Dr Akira Yamasaki, Dr Yasuyuki Hasegawa, Dr Masanari Watanabe, Dr Ryota Okazaki, Dr Naoto Burioka Dr Tadashi Igishi and Prof Eiji Shimizu at Multidisciplinary Internal Medicine, Tottori University; Prof. Takeshi Isobe at Department of Clinical Oncology and Respiratory Medicine, Shimane University: Dr Keiichi Hanaki, at Department of Pediatrics, Tottori University; Dr Takeshi Taketani, Dr Takeshi Kasai and Dr Hitoshi Sejima at Department of Pediatrics, Shimane University; Dr Kazuhiro Kato and Dr Kouji Fukutani at Department of Respiratory Medicine, San-in Rosai Hospital; Dr Yuji Sugimoto at Department of Internal Medicine, Tottori Prefecture Central Hospital; Dr Masahiro Kodani at Department of Internal Medicine, Tottori Red Cross Hospital; Dr Tatsuya Konishi at Department of Respiratory Medicine, Matsue City Hospital; Dr Yuji Kawasaki and Dr Hirokazu Tokuyasu at Department of Respiratory Medicine, Matsue Red Cross Hospital; Dr Toshikazu Ikeda at Department of Respiratory Medicine, National Organization Matsue Hospital; Dr Katsuyuki Tomita and Dr Hiroki Yajima at Department of Internal Medicine, Hakuai Hospital; Dr Masato Hirao at Department of Pediatrics, Tottori Red Cross Hospital; Dr Hiroshi Hayashibara at Department of Pediatrics, National Organization Yonago Medical Center; Dr Yasuhiro Fujii at Department of Respiratory Medicine, Saiseikai Sakaiminato General Hospital; Dr Tohru Hikita at Department of Allergy, Fujii Masao Memorial Hospital; Dr Daisuke Hori at Department of Respiratory Medicine, National Hospital Organization Hamada Medical Center; Dr Satoru Katayama at Department of Respiratory Medicine, Yoka Public Hospital: Dr Koichi Asai at Department of Pediatrics, Shimane Prefecture Hospital; Dr Yumi Negi and Yuuichi Mushimoto at Department of Pediatrics, Unnan General Hospital; Dr Takehisa Fujiwaki at Department of Pediatrics, Oochi General Hospital; Dr Masaru Tasaka at Department of Pediatrics, Tsuwano Kyozon Hospital; Dr Susumu Katsube at Katsube Clinic; Dr Yoshihide Nakamura at Nakamura Internal Medicine and Respiratory Clinic; Dr Hajime Horie at Horie Respiration Clinic; Dr Yuji Matsumoto at Matsumoto Clinic; Dr Takashi Matsuda at Matsuda Pediatric Clinic; Dr Masaaki Honda at Honda Clinic; Dr Sotarou Nogami at Nogami Clinic; Dr Kinya Motoda at Tottori Municipal Hospital, Dr Masato Horiuchi at Horiuchi Clinic; Dr Yuukou Yamane at Yamane Clinic; Dr Masaaki Mikami at Hosshouji Internal Clinic; Dr Tomoaki Koshoubu at Department of Internal Medicine, National Organization Yonago Medical Center; Dr Takashi Yanagawa at Department of Respiratory Medicine, National Hospital Organization Hamada Medical Center; Dr Kazuya Hirakawa at Shimane Prefecuture Preventive Medical Center; Dr Yoshimaro Yamamoto at Department of Internal Medicine, Tottori Prefecture Kousei Hospital; Dr Hiroyuki Yamamoto at Department of Internal Medicine, Saihaku Hosipital; Dr Naoto Kohno at Nichihara Kyozon Hospital; Dr Sumiko Takigawa at Sumire Pediatric Clinic; Noruki Haneda at Mototsune Pediatric Clinic; Dr Hiroshi Watanabe at Watanabe Pediatric and Ladies Clinic; Dr Isonori Senoh at Senoh Clinic; Dr Takaharu Ohie at Oda Municipal Hospital; Dr Yuichi Tagusa at Poyopoyo Clinic; Dr Yasuhisa Kajino at Department of Pediatrics, Masuda Red Cross Hospital; Dr Tadataka Hoshika at Department of Pediatrics, Tottori Prefecture Central Hospital; Dr Nobuo Ishitani at Ishitani Pediatric Clinic; Dr Teruo Okasora at Okasora Pediatric Clinic, Dr Junji Takagi at Department of Pediatrics, Gotsu Saiseikai General Hospital; Dr Seiko Yamane at Department of Pediatrics, Matsue Memorial Hospital; Dr Yasuo Nishino at Nishino Pediatric Clinic; Dr Hirohumi Urashima at Urashima Clinic.

![Distribution of age of patients with cough. The number of patients with acute and subacute cough is larger under the age of 40 years compared to the number of patients with chronic cough. The number of patients with chronic cough was larger compared to the number of patients with acute and subacute cough in most of the generation aged more than 50 years.](ijgm-3-101f1){#f1-ijgm-3-101}

![The percentage of antiasthmatic drug used by patients with asthma/CVA according to the duration of cough. The percentage of ICS use increased according to the duration of cough (acute, 42%; subacute, 70%; chronic, 100%). The percentage of LTRA use also increased according to the duration of cough (acute, 30%; subacute, 40%; chronic, 60%). The percentage of LABA use decreased according to the duration of cough (acute, 58%; subacute, 42%; chronic, 40%). The percentages of sustained-release theophylline use did not correlate with the duration of asthma (acute, 40%; subacute, 20%; chronic, 29%).\
**Abbreviations:** CVA, cough variant asthma; ICS, inhaled corticosteroids; LABA, long-acting β~2~-agonists; LTRA, leukotriene receptor antagonist.](ijgm-3-101f2){#f2-ijgm-3-101}

###### 

Questionnaire (originally described in Japanese)

  ---------------------------------------------------------------- ------------------------ --
  1\. How long has it been since you have had cough?                                        
   □ within one week                                               □ within two weeks       
   □ within three weeks                                            □ within one month       
   □ one to two months                                             □ more than two months   
  2\. Do you have symptoms such as wheezing or chest oppression?                            
   □ Yes                                                           □ No                     
  ---------------------------------------------------------------- ------------------------ --

###### 

Characteristics of patients

                         **Total**   **Acute**   **Subacute**   **Chronic**
  ---------------------- ----------- ----------- -------------- -------------------------------------------------
  Number of patients     114         25          41             54
  Average age (years)    50.5        44.4        45.2           57.4[\*](#tfn1-ijgm-3-101){ref-type="table-fn"}
    Standard deviation   17.4        19.7        14.1           16.4
    Range                18--74      18--78      20--82         20--84
  Gender (female %)      67.5        76.0        63.4           64.8

*P \<* 0.01, compared to acute or subacute groups.

###### 

Causes of acute, subacute and chronic cough

                                     **Acute**   **Subacute**   **Chronic**
  ---------------------------------- ----------- -------------- -------------
  Asthma                             28.0%       48.8%          44.5%
  CVA                                0%          9.7%           9.3%
  Respiratory tract infection        72.0%       7.3%           0%
  Post infectious cough              0%          12.2%          11.1%
  COPD                               0%          4.8%           14.8%
  SBS                                0%          2.4%           7.4%
  Bronchiolitis associated with RA   0%          2.4%           3.7%
  GERD                               0%          0%             4.8%
  Unknown                            0%          12.2%          9.3%

###### 

Clinical tests and symptoms performed for the diagnosis of asthma/CVA

                                                            **Acute**   **Subacute**   **Chronic**
  --------------------------------------------------------- ----------- -------------- -------------
  Chest X-ray test                                          57.1%       95.8%          100.0%
  White blood cell count                                    42.8%       58.3%          91.7%
  IgE                                                       14.3%       25.0%          72.4%
  Sputum eosinophil                                         42.8%       37.5%          51.7%
  Spirometry                                                57.1%       70.8%          79.3%
  Typical symptoms of asthma (wheezing, chest oppression)   85.7%       54.2%          82.8%
